Dr. Sandey’s research focuses on molecular profiling, molecular classification and comparative aspects of canine cancer. His laboratory is developing novel adenoviral vectors for both oncolytic virotherapy and delivery of genes with antitumor properties such as canine melanoma differentiation associated gene-7. The laboratory is also developing novel molecular diagnostic and prognostic assays.
In addition, his laboratory is characterizing a liver specific knockout mouse model of human Niemann Pick disease type C.
